Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sokol

Showing results (161-170 of 259) with videos related to

Pageof 26
Sort By:
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
Plos One|May 7, 2020
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumorsJacob Rinaldi, Ethan S Sokol, Ryan J Hartmaier, et al.
Cell Reports|July 11, 2019
Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary EpitheliumKayla M Gross, Wenhui Zhou, Jerrica L Breindel, et al.
Oncogene|January 22, 2022
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropismShani Journo, Anat Klein Goldberg, Ethan S Sokol, et al.
G3 (Bethesda, Md.)|September 25, 2020
Identification and Characterization of Breakpoints and Mutations on <i>Drosophila melanogaster</i> Balancer ChromosomesDanny E Miller, Lily Kahsai, Kasun Buddika, et al.
The Oncologist|March 3, 2023
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry AssayNatalie Danziger, Ethan S Sokol, Ryon P Graf, et al.
The Oncologist|October 4, 2019
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current EvidenceSamuel J Klempner, David Fabrizio, Shalmali Bane, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1989
Naltrexone in autistic children: an acute open dose range tolerance trialM Campbell, J E Overall, A M Small, et al.
BJC Reports|November 8, 2024
Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumorsEylül Özgü, Benjamin G Kaplan, Smruthy Sivakumar, et al.
The American Journal of Psychiatry|January 1, 1985
Cognitive function after coronary bypass surgery: effect of decreased cerebral blood flowA M Freeman, D G Folks, R S Sokol, et al.
Pageof 26

Showing results (161-170 of 259) with videos related to

Sort By:
Pageof 26
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
Plos One|May 7, 2020
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumorsJacob Rinaldi, Ethan S Sokol, Ryan J Hartmaier, et al.
Cell Reports|July 11, 2019
Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary EpitheliumKayla M Gross, Wenhui Zhou, Jerrica L Breindel, et al.
Oncogene|January 22, 2022
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropismShani Journo, Anat Klein Goldberg, Ethan S Sokol, et al.
G3 (Bethesda, Md.)|September 25, 2020
Identification and Characterization of Breakpoints and Mutations on <i>Drosophila melanogaster</i> Balancer ChromosomesDanny E Miller, Lily Kahsai, Kasun Buddika, et al.
The Oncologist|March 3, 2023
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry AssayNatalie Danziger, Ethan S Sokol, Ryon P Graf, et al.
The Oncologist|October 4, 2019
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current EvidenceSamuel J Klempner, David Fabrizio, Shalmali Bane, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1989
Naltrexone in autistic children: an acute open dose range tolerance trialM Campbell, J E Overall, A M Small, et al.
BJC Reports|November 8, 2024
Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumorsEylül Özgü, Benjamin G Kaplan, Smruthy Sivakumar, et al.
The American Journal of Psychiatry|January 1, 1985
Cognitive function after coronary bypass surgery: effect of decreased cerebral blood flowA M Freeman, D G Folks, R S Sokol, et al.
Pageof 26